Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02935686
What this trial is testing

A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 155
Early research (Phase 1)Study completedNCT05900154
What this trial is testing

Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Pfizer 128
Early research (Phase 1)Study completedNCT00343005
What this trial is testing

Experimental Vaccine for Malaria in Adults in Mali

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 54
Large-scale testing (Phase 3)Study completedNCT03965962
What this trial is testing

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults

Who this might be right for
Rabies (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 640
Early research (Phase 1)Study completedNCT00000886
What this trial is testing

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT03814720
What this trial is testing

Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults

Who this might be right for
Influenza Infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT00053482
What this trial is testing

Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults

Who this might be right for
Smallpox
Emergent BioSolutions 357
Early research (Phase 1)Study completedNCT05135273
What this trial is testing

Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali

Who this might be right for
Malaria,Falciparum
National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)Study completedNCT03393754
What this trial is testing

Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults

Who this might be right for
Hepatitis B Vaccines
VBI Vaccines Inc. 1,607
Early research (Phase 1)Study completedNCT01966224
What this trial is testing

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Who this might be right for
Allergic Rhinoconjunctivitis
Immunomic Therapeutics, Inc. 17
Early research (Phase 1)Study completedNCT04519073
What this trial is testing

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Who this might be right for
Acute Bronchiolitis Due to Respiratory Syncytial Virus
Virometix 60
Early research (Phase 1)UnknownNCT05552573
What this trial is testing

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 100
Early research (Phase 1)Study completedNCT01779505
What this trial is testing

A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults

Who this might be right for
Healthy Volunteers
Gilead Sciences 60
Early research (Phase 1)Study completedNCT00001445
What this trial is testing

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT06719219
What this trial is testing

A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.

Who this might be right for
Staphylococcus (S.) Aureus Infection
LimmaTech Biologics AG 129
Early research (Phase 1)Study completedNCT04619628
What this trial is testing

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

Who this might be right for
COVID-19
Codagenix, Inc 48
Testing effectiveness (Phase 2)Study completedNCT03824236
What this trial is testing

Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults

Who this might be right for
Malaria
GlaxoSmithKline 61
Large-scale testing (Phase 3)Study completedNCT01954251
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 829
Early research (Phase 1)Study completedNCT00613665
What this trial is testing

Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults

Who this might be right for
Helicobacter PyloriGastritisGastric Cancer+2 more
Novartis Vaccines 113
Testing effectiveness (Phase 2)Study completedNCT04681092
What this trial is testing

Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study

Who this might be right for
Covid19
University Medical Center Groningen 112
Next Page